 TORONTO and HOUSTON, Feb. 02, 2022 GLOBE NEWSWIRE -- Medicenna Therapeutics Corp. Medicenna or the Company NASDAQ: MDNA TSX: MDNA, a clinical stage immuno-oncology company, today announced that it will host a conference call and live webcast on February 9, 2022 at 8:30 AM ET to report its third quarter fiscal 2022 financial results and operational highlights. 